166 related articles for article (PubMed ID: 34238114)
1. Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features.
Lei Y; Tang R; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Wang W; Shi S
Bioengineered; 2021 Dec; 12(1):3593-3602. PubMed ID: 34238114
[TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic immune-related lncRNAs in pancreatic cancer.
Ma Y; He X; Di Y; Liu S; Zhan Q; Bai Z; Qiu T; Corpe C; Wang J
Front Immunol; 2022; 13():1005695. PubMed ID: 36420274
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
4. Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer.
Liu S; Peng X; Wu X; Bu F; Yu Z; Zhu J; Luo C; Zhang W; Liu J; Huang J
World J Surg Oncol; 2022 Mar; 20(1):71. PubMed ID: 35249533
[TBL] [Abstract][Full Text] [Related]
5. Immune-Related LncRNAs as Prognostic Factors for Pediatric Rhabdoid Tumor of the Kidney.
Hong Y; Que Y; Hu Y; Shi BY; Zhu J; Wang J; Huang JT; Sun FF; Zhang L; Zhou XK; Lu SY; Zhang YZ
Dis Markers; 2022; 2022():4752184. PubMed ID: 35756490
[TBL] [Abstract][Full Text] [Related]
6. Construction of immune-related lncRNA signature to predict aggressiveness, immune landscape, and drug resistance of colon cancer.
Xue Y; Ning B; Liu H; Jia B
BMC Gastroenterol; 2022 Mar; 22(1):127. PubMed ID: 35300596
[TBL] [Abstract][Full Text] [Related]
7. Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma.
Cao K; Liu M; Ma K; Jiang X; Ma J; Zhu J
Cancer Immunol Immunother; 2022 Jun; 71(6):1295-1311. PubMed ID: 34652523
[TBL] [Abstract][Full Text] [Related]
8. Signature involved in immune-related lncRNA pairs for predicting the immune landscape of cervical cancer.
Liu X; Wang Z; Wang L; Wang Y; Wang Y; Yang S; Zhang Y
Int J Biol Markers; 2022 Jun; 37(2):191-199. PubMed ID: 35435763
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma.
Yuan H; Liu J; Zhao L; Wu P; Chen G; Chen Q; Shen P; Yang T; Fan S; Xiao B; Jiang K
Front Immunol; 2021; 12():800268. PubMed ID: 34956238
[TBL] [Abstract][Full Text] [Related]
10. Construction of a novel signature based on immune-related lncRNA to identify high and low risk pancreatic adenocarcinoma patients.
Li N; Chen J; Yu W; Huang X
BMC Gastroenterol; 2023 Sep; 23(1):312. PubMed ID: 37710166
[TBL] [Abstract][Full Text] [Related]
11. Using immune-related lncRNAs to construct novel biomarkers and investigate the immune landscape of breast cancer.
Qin M; Ma Y; Wang Z; Fang D; Wei J
Transl Cancer Res; 2021 Jun; 10(6):2991-3003. PubMed ID: 35116607
[TBL] [Abstract][Full Text] [Related]
12. A robust immune-related lncRNA signature for the prognosis of human colorectal cancer.
Zhu G; Pei L; Yang F; Zhang C
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35506372
[TBL] [Abstract][Full Text] [Related]
13. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.
Hu Y; Chen Y
Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel immune-related lncRNA signature to predict prognostic outcome and therapeutic efficacy of LGG.
Wu D; Wang X; Xue Y; Sun C; Zhang M
J Integr Neurosci; 2022 Mar; 21(2):55. PubMed ID: 35364643
[TBL] [Abstract][Full Text] [Related]
15. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
[TBL] [Abstract][Full Text] [Related]
16. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer.
Xu M; Li Q; Zhang J; Xie H
Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
[TBL] [Abstract][Full Text] [Related]
17. Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.
Liu B; Fu T; He P; Du C; Xu K
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34143198
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients.
Shao J; Zhang B; Kuai L; Li Q
Bioengineered; 2021 Dec; 12(1):6186-6200. PubMed ID: 34486476
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma.
Lin Z; Pang K; Li H; Zhang X; Wan J; Zheng T; Liu T; Peng W
Front Cell Dev Biol; 2021; 9():709241. PubMed ID: 34631703
[No Abstract] [Full Text] [Related]
20. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Xiao R; Yang M; Tan Y; Ding R; Li D
Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
